US 9505826
Modified antibody with improved half-life
granted A61PA61P1/00A61P1/04
Quick answer
US patent 9505826 (Modified antibody with improved half-life) held by TEVA PHARMACEUTICALS AUSTRALIA PTY LTD expires Mon Nov 24 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- TEVA PHARMACEUTICALS AUSTRALIA PTY LTD
- Grant date
- Tue Nov 29 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 24 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61P, A61P1/00, A61P1/04, A61P1/14, A61P11/00